Sunday, July 19, 2020 11:00:31 AM
New EIGR LAMBDA Trial in Canada -Why would Ontario be starting a new Lambda Trial without positive interim data in this SINGLE BLINDED trial - so Stanford researchers know that this 28 day follow up Trial is working and are sharing this fact with their colleagues in Canada. Dr Feld - Principal Investigator in Canada trained at the NIH and Hopkins.
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Open-label, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
Jordan Feld, Principal Investigator
University Health Network
Researchers will evaluate the drug peginterferon-lambda (PegIFN-) in ambulatory and hospitalized patients with mild to moderate COVID-19. Peginterferon-lambda has already been used to treat other viral diseases, such as hepatitis B and C. This research will shed light on whether it improves the ability of individuals to clear the virus that causes COVID-19.
https://news.ontario.ca/opo/en/2020/07/ontario-announces-next-round-of-research-projects-to-fight-covid-19.html
Recent EIGRQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 12:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:06:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 09:00:57 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM